DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 152 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $12,967,843 | +52.8% | 824,402 | +56.6% | 0.68% | +50.3% |
Q4 2023 | $8,488,751 | -40.7% | 526,271 | +64.9% | 0.45% | -5.5% |
Q1 2021 | $14,313,000 | -21.4% | 319,202 | 0.0% | 0.48% | -25.1% |
Q4 2020 | $18,217,000 | +43.3% | 319,202 | +28.8% | 0.63% | +12.6% |
Q3 2020 | $12,709,000 | +11.7% | 247,748 | +30.1% | 0.56% | +4.8% |
Q2 2020 | $11,376,000 | +183.6% | 190,482 | +95.5% | 0.54% | +113.9% |
Q1 2020 | $4,011,000 | -51.2% | 97,432 | -73.2% | 0.25% | -23.0% |
Q2 2019 | $8,211,000 | -2.8% | 364,105 | 0.0% | 0.33% | -3.8% |
Q1 2019 | $8,451,000 | -34.4% | 364,105 | -40.6% | 0.34% | -43.7% |
Q4 2018 | $12,873,000 | -50.2% | 613,281 | -8.1% | 0.60% | -31.0% |
Q3 2018 | $25,836,000 | +28.2% | 667,262 | +30.3% | 0.87% | +19.6% |
Q2 2018 | $20,154,000 | +132.2% | 512,180 | +18.3% | 0.73% | +114.7% |
Q1 2018 | $8,679,000 | -8.0% | 433,060 | +4.0% | 0.34% | -9.3% |
Q4 2017 | $9,438,000 | +70.1% | 416,342 | +42.5% | 0.38% | +62.3% |
Q3 2017 | $5,548,000 | – | 292,147 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $19,824,869 | 14.35% |
Redmile Group, LLC | 3,593,317 | $58,894,466 | 2.41% |
BRAIDWELL LP | 3,271,513 | $53,620,098 | 1.80% |
Parkman Healthcare Partners LLC | 344,920 | $5,653,239 | 1.50% |
ARMISTICE CAPITAL, LLC | 5,172,000 | $84,769,080 | 1.48% |
Ikarian Capital, LLC | 367,119 | $6,017,081 | 1.45% |
Sunesis Advisors, LLC | 96,299 | $1,578,341 | 1.01% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,349,228 | $38,503,847 | 0.80% |
Hillsdale Investment Management Inc. | 328,200 | $5,379,198 | 0.46% |
Avidity Partners Management LP | 1,126,000 | $18,455,140 | 0.40% |